slotkoers
Korea S.E.
00:00:00 31-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
12.070
KRW
|
-0,25%
|
|
-2,43%
|
+7,58%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
210.487
|
137.400
|
166.285
|
133.300
|
86.918
|
76.789
|
Bedrijfswaarde
1 |
148.321
|
79.102
|
112.743
|
76.293
|
22.508
|
8.012
|
K/w-verhouding
|
10,9
x
|
19,4
x
|
52,3
x
|
12,8
x
|
10,6
x
|
12,2
x
|
Dividendrendement
|
2,14%
|
3,17%
|
1,91%
|
2,39%
|
3,54%
|
4,01%
|
Marktkapitalisatie/omzet
|
3,37
x
|
2,99
x
|
3,65
x
|
2,84
x
|
1,72
x
|
1,43
x
|
Bedrijfswaarde/omzet
|
2,37
x
|
1,72
x
|
2,47
x
|
1,63
x
|
0,45
x
|
0,15
x
|
Bedrijfswaarde/EBITDA
|
6,3
x
|
9,4
x
|
15,3
x
|
6,91
x
|
2,32
x
|
1,31
x
|
Bedrijfswaarde/FCF
|
262
x
|
29,1
x
|
36,9
x
|
8,29
x
|
4,06
x
|
-23,9
x
|
FCF Yield
|
0,38%
|
3,44%
|
2,71%
|
12,1%
|
24,6%
|
-4,19%
|
Price to Book
|
1,99
x
|
1,36
x
|
1,67
x
|
1,25
x
|
0,8
x
|
0,69
x
|
Aantal aandelen (in duizenden)
|
7.504
|
7.251
|
7.076
|
7.072
|
6.844
|
6.844
|
Referentieprijs
2 |
28.050
|
18.950
|
23.500
|
18.850
|
12.700
|
11.220
|
Datum van publicatie
|
13-03-19
|
18-03-20
|
17-03-21
|
22-03-22
|
15-03-23
|
19-03-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
62.544
|
45.960
|
45.582
|
46.873
|
50.526
|
53.787
|
EBITDA
1 |
23.547
|
8.415
|
7.352
|
11.046
|
9.689
|
6.100
|
Bedrijfsresultaat (EBIT)
1 |
21.675
|
5.795
|
3.667
|
7.257
|
6.051
|
2.195
|
Operationele Marge
|
34,66%
|
12,61%
|
8,05%
|
15,48%
|
11,98%
|
4,08%
|
Resultaat voor belastingen (EBT)
1 |
23.861
|
8.307
|
2.402
|
12.090
|
10.172
|
6.880
|
Nettowinst (verlies)
1 |
19.384
|
7.231
|
3.189
|
10.383
|
8.281
|
6.304
|
Nettomarge
|
30,99%
|
15,73%
|
7%
|
22,15%
|
16,39%
|
11,72%
|
WPA
2 |
2.583
|
975,9
|
449,6
|
1.468
|
1.201
|
921,0
|
Free Cash Flow
1 |
565,7
|
2.721
|
3.057
|
9.207
|
5.547
|
-335,6
|
FCF-marge
|
0,9%
|
5,92%
|
6,71%
|
19,64%
|
10,98%
|
-0,62%
|
Kasstroomconversie (ebitda)
|
2,4%
|
32,34%
|
41,58%
|
83,35%
|
57,25%
|
-
|
Kasstroomconversie (nettowinst)
|
2,92%
|
37,63%
|
95,86%
|
88,67%
|
66,99%
|
-
|
Dividend per aandeel
2 |
600,0
|
600,0
|
450,0
|
450,0
|
450,0
|
450,0
|
Datum van publicatie
|
13-03-19
|
18-03-20
|
17-03-21
|
22-03-22
|
15-03-23
|
19-03-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
62.166
|
58.299
|
53.542
|
57.007
|
64.409
|
68.777
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
566
|
2.721
|
3.057
|
9.207
|
5.547
|
-336
|
ROE (netto-inkomsten/eigen vermogen)
|
19,8%
|
6,91%
|
3,13%
|
10%
|
7,71%
|
5,73%
|
ROA (netto-inkomsten/totale activa)
|
13%
|
3,29%
|
2,15%
|
4,16%
|
3,31%
|
1,18%
|
Totale activa
1 |
149.190
|
219.984
|
148.611
|
249.757
|
250.375
|
536.350
|
Nettoactief per aandeel
2 |
14.076
|
13.983
|
14.094
|
15.087
|
15.794
|
16.348
|
Cashflow per aandeel
2 |
1.778
|
1.272
|
1.353
|
1.394
|
1.236
|
1.152
|
Capex
1 |
7.109
|
9.468
|
3.079
|
849
|
2.368
|
1.552
|
Capex/omzet
|
11,37%
|
20,6%
|
6,75%
|
1,81%
|
4,69%
|
2,88%
|
Datum van publicatie
|
13-03-19
|
18-03-20
|
17-03-21
|
22-03-22
|
15-03-23
|
19-03-24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| +7,58% | 59,73 mln. | | +11,60% | 106 mld. | | -4,68% | 24,28 mld. | | -0,82% | 21,96 mld. | | -10,12% | 18,16 mld. | | -42,12% | 16,37 mld. | | -17,47% | 15,56 mld. | | +2,77% | 13,63 mld. | | +34,58% | 12,27 mld. | | +77,64% | 8,87 mld. |
Biotherapeutische geneesmiddelen
|